{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:19:22Z","timestamp":1791501562572,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11481-016-9720-7","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T01:36:21Z","timestamp":1481938581000},"page":"327-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson\u2019s Disease, Shifting M1 to M2 Microglia Responses"],"prefix":"10.1007","volume":"12","author":[{"given":"Rosa","family":"Calvello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Cianciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nicolardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Nuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Porro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Panaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario Domenico","family":"Lofrumento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"9720_CR1","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Yera D, Mart\u00ednez-Pag\u00e1n ME, de Pablos V, Fernandez-Villalba E, Herrero MT (2011) IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis 2:e142","journal-title":"Cell Death Dis"},{"key":"9720_CR2","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.4049\/jimmunol.181.6.3733","volume":"181","author":"M Benoit","year":"2008","unstructured":"Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181:3733\u20133739","journal-title":"J Immunol"},{"key":"9720_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11481-013-9435-y","volume":"8","author":"F Blandini","year":"2013","unstructured":"Blandini F (2013) Neural and immune mechanisms in the pathogenesis of Parkinson\u2019s disease. J NeuroImmune Pharmacol 8:189\u2013201","journal-title":"J NeuroImmune Pharmacol"},{"key":"9720_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77\u201398","journal-title":"Prog Neurobiol"},{"key":"9720_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jneuroim.2016.01.015","volume":"292","author":"M Boontanrart","year":"2016","unstructured":"Boontanrart M, Hall SD, Spanier JA, Hayes CE, Olson JK (2016) Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism. J Neuroimmunol 292:126\u2013136","journal-title":"J Neuroimmunol"},{"key":"9720_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fimmu.2011.00062","volume":"2","author":"L Bosurgi","year":"2011","unstructured":"Bosurgi L, Manfredi AA, Rovere-Querini P (2011) Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol 2:62","journal-title":"Front Immunol"},{"key":"9720_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"9720_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen H, O\u2019Reilly EJ, Schwarzschild MA, Ascherio A (2008) Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol 167:90\u201395","journal-title":"Am J Epidemiol"},{"key":"9720_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","volume":"37","author":"AL De Lella Ezcurra","year":"2010","unstructured":"De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F (2010) Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/macrophage activation. Neurobiol Dis 37:630\u2013640","journal-title":"Neurobiol Dis"},{"key":"9720_CR10","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1046\/j.1460-9568.2002.02283.x","volume":"16","author":"TC Sampaio e Spohr de","year":"2002","unstructured":"de Sampaio e Spohr TC, Martinez R, da Silva EF, Neto VM, Gomes FC (2002) Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factorbeta1. Eur J Neurosci 16:2059\u20132069","journal-title":"Eur J Neurosci"},{"key":"9720_CR11","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.4049\/jimmunol.1103180","volume":"189","author":"B Deng","year":"2012","unstructured":"Deng B, Wehling-Henricks M, Villalta SA, Wang Y, Tidball JG (2012) IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 189:3669\u20133680","journal-title":"J Immunol"},{"key":"9720_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin M, Clement F, Fattaccioli A, Raes M, Michiels C (2015) M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 15:577","journal-title":"BMC Cancer"},{"key":"9720_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","volume":"274","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Elgueta D, Montoya A, Pacheco R (2014) Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J Neuroimmunol 274:1\u201313","journal-title":"J Neuroimmunol"},{"key":"9720_CR14","doi-asserted-by":"publisher","unstructured":"Gutierrez J, Raju S, Riley JP, Boulis NM (2014) Introduction to neuropathic pain syndromes. Neurosurg Clin N Am 25:639-662","DOI":"10.1016\/j.nec.2014.06.002"},{"key":"9720_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"9720_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106:518\u2013526","journal-title":"Acta Neuropathol"},{"key":"9720_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","volume":"32","author":"D Ito","year":"2001","unstructured":"Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y (2001) Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32:1208\u20131215","journal-title":"Stroke"},{"key":"9720_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2:141\u2013151","journal-title":"Nat Protoc"},{"key":"9720_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5717\/jenb.2015.15060203","volume":"19","author":"JH Jeong","year":"2015","unstructured":"Jeong JH, Lee YR, Park HG, Lee WL (2015) The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice. J Exerc Nutrition Biochem 19:65\u201372","journal-title":"J Exerc Nutrition Biochem"},{"key":"9720_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347","journal-title":"Exp Mol Med"},{"key":"9720_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3988\/jcn.2006.2.4.252","volume":"4","author":"JS Kim","year":"2006","unstructured":"Kim JS, Ryu SY, Yun I, Kim WJ, Lee KS, Park JW, Kim YI (2006) 1alpha,25-dihydroxyvitamin D(3) protects dopaminergic neurons in rodent models of Parkinson\u2019s disease through inhibition of microglial activation. J Clin Neurol 4:252\u2013257","journal-title":"J Clin Neurol"},{"key":"9720_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2013.08.012","volume":"154","author":"TH Kim","year":"2013","unstructured":"Kim TH, Lee B, Kwon E, Choi SJ, Lee YH, Song GG, Sohn J, Ji JD (2013) Regulation of TREM-1 expression by 1,25-dihydroxyvitamin D3 in human monocytes\/macrophages. Immunol Lett 154:80\u201385","journal-title":"Immunol Lett"},{"key":"9720_CR23","first-page":"239","volume":"96","author":"PM Kou","year":"2011","unstructured":"Kou PM, Babensee JE (2011) Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A 96:239\u2013260","journal-title":"J Biomed Mater Res A"},{"key":"9720_CR24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","volume":"14","author":"K Krieglstein","year":"1995","unstructured":"Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K (1995) TGF-\u03b2 superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 14:736\u2013742","journal-title":"EMBO J"},{"key":"9720_CR25","first-page":"53","volume":"7","author":"MC Leal","year":"2013","unstructured":"Leal MC, Casabona JC, Puntel M, Pitossi FJ (2013) Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets for protective therapies in Parkinson\u2019s disease? Front Cell Neurosci 7:53","journal-title":"Front Cell Neurosci"},{"key":"9720_CR26","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"9720_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuroscience.2007.01.004","volume":"146","author":"M Letiembre","year":"2007","unstructured":"Letiembre M, Hao W, Liu Y, Walter S, Mihaljevic I, Rivest S, Hartmann T, Fassbender K (2007) Innate immune receptor expression in normal brain aging. Neuroscience 146:248\u2013254","journal-title":"Neuroscience"},{"key":"9720_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000320027","volume":"18","author":"DD Lofrumento","year":"2011","unstructured":"Lofrumento DD, Saponaro C, Cianciulli A, De Nuccio F, Mitolo V, Nicolardi G, Panaro MA (2011) MPTP-induced neuroinflammation increases the expression of proinflammatory cytokines and their receptors in mouse brain. Neuroimmunomodulation 18:79\u201388","journal-title":"Neuroimmunomodulation"},{"key":"9720_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1753425913488429","volume":"20","author":"DD Lofrumento","year":"2014","unstructured":"Lofrumento DD, Nicolardi G, Cianciulli A, De Nuccio F, La Pesa V, Carofiglio V, Dragone T, Calvello R, Panaro MA (2014) Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson\u2019s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun 20:249\u2013260","journal-title":"Innate Immun"},{"key":"9720_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45","journal-title":"J Neuroinflammation"},{"key":"9720_CR31","first-page":"19","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Park Dis 1:19\u201333","journal-title":"J Park Dis"},{"key":"9720_CR32","doi-asserted-by":"publisher","unstructured":"Moore KW, deWaal MR, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"9720_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri2378","volume":"8","author":"JR Mora","year":"2008","unstructured":"Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins a and D take Centre stage. Nat Rev Immunol 8:685\u2013698","journal-title":"Nat Rev Immunol"},{"key":"9720_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2006","unstructured":"Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2006) Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin Neurosci Res 6:261\u2013281","journal-title":"Clin Neurosci Res"},{"key":"9720_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12640-013-9422-3","volume":"25","author":"CA Mstriatumherson","year":"2014","unstructured":"Mstriatumherson CA, Merrick BA, Harry GJ (2014) In vivo molecular markers for pro-inflammatory cytokine M1 stage and resident microglia in trimethyltin-induced hippocampal injury. Neurotox Res 25:45\u201356","journal-title":"Neurotox Res"},{"key":"9720_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000343104","volume":"61","author":"AW Norman","year":"2012","unstructured":"Norman AW (2012) The history of the discovery of vitamin D and its daughter steroid hormone. Ann Nutr Metab 61:199\u2013206","journal-title":"Ann Nutr Metab"},{"key":"9720_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ana.24011","volume":"74","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Schapira AH (2013) Therapeutic prospects for Parkinson disease. Ann Neurol 74:337\u2013347","journal-title":"Ann Neurol"},{"key":"9720_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/08923970802278557","volume":"30","author":"MA Panaro","year":"2008","unstructured":"Panaro MA, Lofrumento DD, Saponaro C, De Nuccio F, Cianciulli A, Mitolo V, Nicolardi G (2008) Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson\u2019s-like disease. Immunopharmacol Immunotoxicol 30:729\u2013740","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9720_CR39","doi-asserted-by":"publisher","first-page":"2715196","DOI":"10.1155\/2016\/2715196","volume":"2016","author":"A Pikhovych","year":"2016","unstructured":"Pikhovych A, Stolberg NP, Jessica Flitsch L, Walter HL, Graf R, Fink GR, Schroeter M, Rueger MA (2016) Transcranial direct current stimulation modulates neurogenesis and microglia activation in the mouse brain. Stem Cells Int 2016:2715196","journal-title":"Stem Cells Int"},{"key":"9720_CR40","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/brain\/awn101","volume":"131","author":"MC Pott Godoy","year":"2008","unstructured":"Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease. Brain 131:1880\u20131894","journal-title":"Brain"},{"key":"9720_CR41","doi-asserted-by":"publisher","unstructured":"Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331-344","DOI":"10.1016\/j.cytogfr.2010.09.002"},{"key":"9720_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jnr.21878","volume":"87","author":"B Sanchez","year":"2009","unstructured":"Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R (2009) 1,25-dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res 87:723\u2013732","journal-title":"J Neurosci Res"},{"key":"9720_CR43","doi-asserted-by":"publisher","unstructured":"Saraiva M, O\u2019Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181","DOI":"10.1038\/nri2711"},{"key":"9720_CR44","doi-asserted-by":"publisher","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O\u2019Callaghan JP (2006) Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J 20:670\u2013682","DOI":"10.1096\/fj.05-5106com"},{"key":"9720_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510\u2013518","journal-title":"Neurobiol Dis"},{"key":"9720_CR46","doi-asserted-by":"publisher","unstructured":"Tarazi FI, Sahli Z, Wolny M, Mousa SA (2014) Emerging therapies for Parkinson\u2019s disease: from bench to bedside. Pharmacol Ther 144:123-133","DOI":"10.1016\/j.pharmthera.2014.05.010"},{"key":"9720_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.10332","volume":"18","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Cohen O, Choi DK, Wu DC, Marks D, Vila M, Jackson-Lewis V, Przedborski S (2003) Pathogenic role of glial cells in Parkinson\u2019s disease. Mov Disord 18:121\u2013129","journal-title":"Mov Disord"},{"key":"9720_CR48","first-page":"70","volume":"196","author":"K Unsicker","year":"1996","unstructured":"Unsicker K, Suter-Crazzalora C, Krieglstein K (1996) Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-fl. CIBA Found Symp 196:70\u201380","journal-title":"CIBA Found Symp"},{"key":"9720_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00005-012-0181-2","volume":"60","author":"MM Varnum","year":"2012","unstructured":"Varnum MM, Ikezu T (2012) The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer\u2019s disease brain. Arch Immunol Ther Exp 60:251\u2013266","journal-title":"Arch Immunol Ther Exp"},{"key":"9720_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000444300","volume":"23","author":"R Verma","year":"2016","unstructured":"Verma R, Kim JY (2016) 1,25-dihydroxyvitamin D3 facilitates M2 polarization and upregulates TLR10 expression on human microglial cells. Neuroimmunomodulation 23:75\u201380","journal-title":"Neuroimmunomodulation"},{"key":"9720_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","volume":"175","author":"S Walsh","year":"2011","unstructured":"Walsh S, Finn DP, Dowd E (2011) Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson\u2019s disease in the rat. Neuroscience 175:251\u2013261","journal-title":"Neuroscience"},{"key":"9720_CR52","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0028-3908(99)00255-5","volume":"39","author":"Y Wang","year":"2000","unstructured":"Wang Y, Chiang YH, Su TP, Hayashi T, Morales M, Hoffer BJ, Lin SZ (2000) Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39:873\u2013880","journal-title":"Neuropharmacology"},{"key":"9720_CR53","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.2174\/138161206778343109","volume":"12","author":"JY Wang","year":"2006","unstructured":"Wang JY, Wen LL, Huang YN, Chen YT, Ku MC (2006) Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12:3521\u20133533","journal-title":"Curr Pharm Des"},{"key":"9720_CR54","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150:963\u2013976","journal-title":"Br J Pharmacol"},{"key":"9720_CR55","doi-asserted-by":"crossref","unstructured":"Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G (2014) Inflammatory response in Parkinson\u2019s disease (review). Mol Med Reports 10:2223-2233\u00a0","DOI":"10.3892\/mmr.2014.2563"},{"key":"9720_CR56","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1161\/ATVBAHA.115.306132","volume":"35","author":"K Yin","year":"2015","unstructured":"Yin K, You Y, Swier V, Tang L, Radwan MM, Pandya AN, Agrawal DK (2015) Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in Hypercholesterolemic swine. Arterioscler Thromb Vasc Biol 35:2432\u20132442","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9720_CR57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2011-101986","volume":"25","author":"J Yu","year":"2011","unstructured":"Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP transgenic mice. J Alzheimers Dis 25:295\u2013307","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-016-9720-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:40:26Z","timestamp":1568637626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-016-9720-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["9720"],"URL":"https:\/\/doi.org\/10.1007\/s11481-016-9720-7","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}